[1] LI R, ZHANG Q F, YANG D Z, et al. Prevalence of polycystic ovary syndrome in women in China:A large community based study[J]. Hum Reprod, 2013, 28(9):2562-2569. [2] LAURITSEN M P, BENTZEN J G, PINBORG A, et al.The prevalence of polycystic ovary syndrome in a normal population according to the Rotterdam criteria versus revised criteria including anti-Mullerian hormone[J].Hum Reprod, 2014, 29(4):791-801. [3] AANDERSSON-SJÖLAND A,HALLGREN O,ROLANDSSON S,et al.Versican in inflammation and tissue remodeling:the impact on lung disorders[J].Glycobiology, 2015, 25(3):243-251. [4] ZHENG X L.Structure-function and regulation of ADAMTS-13 protease[J].J Thromb Haemost, 2013, 11(Suppl 1):11-23. [5] 陈梅,张玲.多能蛋白聚糖在卵巢和子宫中功能的研究进展[J].中国计划生育和妇产科,2015,7(11):14-17. [6] TORTORELLA M, PRATTA M, LIU R Q, et al.The thrombospondin motif of aggrecanase-1(ADAMTS-4) is critical for aggrecan substrate recognition and cleavage[J].J Biol Chem, 2000, 275(33):25791-25797. [7] SOUTH K, FREITAS M O, LANE D A.Conformational quiescence of ADAMTS-13 prevents proteolytic promiscuity[J].J Thromb Haemost, 2016, 14(10):2011-2022. [8] XIAO S, LI Y, LI T, et al.Evidence for decreased expression of ADAMTS-1 associated with impaired oocyte quality in PCOS patients[J].J Clin Endocrinol Metab, 2014, 99(6):E1015-E1021. [9] ÖZLER S, ÖZTA E Ş, TOKMAK A, et al.Role of Versican and ADAMTS-1 in polycystic ovary syndrome[J].J Clin Res Pediatr Endocrinol, 2017, 9(1):24-30. [10] TOLA E N, KARATOPUK D U, KOROGLU N, et al.Follicular ADAMTS-1 and aggrecan levels in polycystic ovary syndrome[J].J Assist Reprod Genet,2017,34(6):811-816. [11] RUSSELL D L, BROWN H M, DUNNING K R.ADAMTS proteases in fertility[J].Matrix Biol,2015,5(44):54-63. [12] TOLA E N, KARATOPUK D U, KOROGLU N, et al.Follicular ADAMTS-1 and aggrecan levels in polycystic ovary syndrome[J].J Assist Reprod Genet,2017,34(6):811-816. [13] TOLA E N, KOROGLU N D, YALCIN S E, et al.The role of serum ADAMTS-1 and aggrecan on polycystic ovary syndrome in adolescents and younger-aged females[J].Arch Gynecol Obstet,2018,297(2):487-493. [14] KARAKOSE M, DEMIRCAN K, TUTAL E, et al.Clinical significance of ADAMTS1, ADAMTS5, ADAMTS9 aggrecanases and IL-17A, IL-23, IL-33 cytokines in polycystic ovary syndrome[J].J Endocrinol Invest,2016,39(11):1269-1275. [15] FOULCER S J,DAY A J,APTE S S.Isolation and purification of versican and analysis of versican proteolysis[J].Methods Mol Biol, 2015, 1229(6):587-604. [16] RUSSELL D L, DOYLE K M H, OCHSNER S A, et al.Processing and localization of ADAMTS-1 and proteolytic cleavage of Versican during cumulus matrix expansion and ovulation[J].J Biol Chem, 2003, 278(43):42330-42339. [17] SANDY J D, WESTLING J, KENAGY R D, et al.Versican V1proteolysis in human aorta in vivo occurs at the Glu441-Ala442 bond,a site that is cleaved by recombinant ADAMTS-1 and ADAMTS-4[J].J Biol Chem, 2001, 276(16):13372-13378. [18] NANDADASA D, FOULCER S, APTE S S.The multiple,complex roles of versican and its proteolytic turnover by ADAMTS proteases during embryogenesis[J].Matrix Biol,2014, 35(5):34-41. [19] HOSSEINPANAH F, BARZIN M, ERFANI H, et al.Lipid accumulation product and insulin resistance in Iranian PCOS prevalence study[J].Clin Endocrinol (Oxf), 2014, 81(1):52-57. [20] NASCIMENTO J X, CHEIN M B, DE SOUSA R M, et al.Importance of lipid accumulation product index as a marker of CVD risk in PCOS women[J].Lipids Health Dis, 2015, 24(14):62. [21] TRIMECHÈ S, THUAN DIT DIEUDONNE J F,JEANDEL C, et al.Polycystic ovary syndrome in pubertal period:clinical,biological,metabolic and genetic polymorphism[J].Gynecol Obstet Fertil, 2004, 32(1):3-17. [22] 赵君利,陈子江,石玉华,等.育龄期妇女体毛状况调查及其在多囊卵巢综合征诊断中的初步应用[J].中华妇产科杂志,2007,42(9):590-594. |